• About us
• Contact

Advertisement

Organisation › Details

Merck (DE) (Group)

Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2025, Merck generated sales of € 21.1 billion in 65 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics. *

 

	Start	1668-01-01 established_pre
	Industry	pharmaceutical
	Industry 2	reagents (bio/biochemical)
	Person	von Roeder, Helene (Merck (DE) 202403 CFO)
	Region	Darmstadt
	Country	Germany
	Street	250 Frankfurter Str.
	City	64293 Darmstadt
	Tel	+49-6151-72-0
		Address record changed: 2024-01-05
Basic data	Employees	I: 50,001 to 100,0 (2025-12-31)
	Currency	EUR
	Annual sales	21,102,000,000 (sales, net, consolidated (2025) 2025-12-31)
	Profit	2,615,000,000 (2025-12-31)
	Cash	2,740,000,000 (2025-12-31)
		* Document for »About Section«: Merck KGaA. (4/21/26). "Press Release: Merck Launches First Bio-based Solvent Portfolio for HPLC". Darmstadt.
		Record changed: 2026-04-25

Advertisement

More documents for Merck (DE) (Group)

• [1] Merck KGaA. (6/8/26). "Press Release: Merck Appoints New Heads of Discovery Solutions and Strategy & BD for Life Science". Darmstadt....
• [2] Merck KGaA. (4/21/26). "Press Release: Merck Launches First Bio-based Solvent Portfolio for HPLC". Darmstadt....
• [3] Merck KGaA. (4/1/26). "Press Release: Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business". Darmstadt....
• [4] Sanofi S.A.. (2/12/26). "Press Release: Belén Garijo to Become Chief Executive Officer of Sanofi". Paris....
• [5] Merck KGaA. (11/20/25). "Press Release: Merck Launches High-Performance Computer to Accelerate Research across Sectors". Darmstadt....
• [6] Merck KGaA. (10/15/25). "Press Release: Merck to Acquire the Chromatography Business of JSR Life Sciences". Darmstadt....
• [7] Merck KGaA. (9/25/25). "Press Release: Kai Beckmann to Succeed Belén Garijo as Chair of the Executive Board and CEO of Merck as of May 2026". Darmstadt....
• [8] Merck KGaA. (2/18/25). "Press Release: New CEOs for Life Science and Healthcare Business Sectors and New Chief People Officer". Darmstadt....
• [9] Merck KGaA. (4/25/24). "Press Release: Merck Invests More Than € 300 Million in New Life Science Research Center in Germany". Darmstadt....
• [10] Merck KGaA. (9/12/23). "Press Release: Merck Appoints Axel Löber as Head of Global Communications and Stakeholder Engagement". Darmstadt....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.